바로가기메뉴

본문 바로가기 주메뉴 바로가기

합병부폐렴삼출 및 농흉의 치료성적과 예후인자

Treatment Results and Prognostic Factors of Complicated Parapneumonic Effusion and Empyema

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.63 no.1, pp.24-30
김영주 (경북의대)
차승익 (경북대학교)
김창호 (경북대학교)
박재용 (경북대학교)
정태훈 (경북대학교)
권지숙 (경북의대)
유승수 (경북의대)
전희정 (경북의대)
김은진 (차의과학대학교)
  • 다운로드 수
  • 조회수

초록

연구배경: 폐렴 환자 중 약 40%에서 흉막삼출이 동반되고 이 가운데 약 10%에서 배액이 필요한 합병부폐렴삼출 또는 농흉으로 진행된다. 저자들은 합병부폐렴삼출 및 농흉 환자에서 치료성적과 예후인자에 대해 알아보고자 하였다.방 법: 2001년 9월부터 2005년 12월까지 합병부폐렴삼출 및 농흉으로 치료받았던 115명의 환자를 대상으로 후향적 연구를 시행하였다.결 과: 대상환자 중 101예(87.8%)에서 치료성공을 보였는데 다변량분석에서 흉막액 LDH 수치(OR 7.37; 95% CI, 1.63-33.37; p=0.009)가 치료성공 및 실패에 중요한 예후인자로 나타났다. 해열기간과 유의한 상관관계를 보인 인자로는 흉막액의 농성여부(r=0.236; p=0.01)와 섬유소용해물질 사용빈도(r=0.257; p=0.01)가 확인되었고 입원기간과 유의한 상관관계를 보인 인자는 없었다.

keywords
Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis., Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis.

Abstract

Background: Pleural effusion develops in approximately 40% of pneumonia patients. In 5-10% of these cases, it progresses to complicated parapneumonic effusion (CPPE) or empyema that requires drainage. The prognostic factors of CPPE and empyema remain to be clarified. We examined the treatment outcomes of CPPE and empyema and elucidating their prognostic factors. Methods: One hundred and fifteen patients with CPPE or empyema, who were diagnosed and treated in Kyungpook National University Hospital (Daegu, Korea) between September 2001 and December 2005, were retrospectively analyzed. All the data was acquired from their chart review, and regarding treatment results, the time to defervescence and the length of hospital stay were analyzed. Results: The treatment was successful in 101 patients with a success rate of 87.8%. Multivariate analysis showed the level of pleural fluid lactate dehydrogenase (LDH) to be a significant prognostic factor (odds ratio [OR] 7.37; 95% confidence interval [CI], 1.63 to 33.37; p=0.009). Pussy pleural fluid (r=0.236; p=0.01) and the frequency of urokinase use (r=0.257; p=0.01) correlated with the time to defervescence. However, there was no clinical factor that correlated with the length of hospital stay. Conclusion: The pleural fluid LDH level is a useful prognostic factor for monitoring treatment results of CPPE and empyema. (Tuberc Respir Dis 2007; 63: 24-30)

keywords
Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis., Empyema, Lactate dehydrogenase, Pleural effusion, Pneumonia, Prognosis.

참고문헌

1.

(2006) Parapneumonic effusions and empyema,

2.

(1996) Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? ,

3.

Webb WR. Management of nontuberculous empyema a statement of the subcommittee on surgery. Am Rev Respir Dis 1962,

4.

(1997) Parapneumonic effusion and empyema,

5.

(2005) Percutaneous management of parapneumonic effusions,

6.

Empyema thoracis: medical aspects of evaluation and treatment,

7.

(1999) Prediction of outcome and long-term survival in patients with pleural infection,

8.

(2005) Factors influencing length of hospital stay in patients with bacterial pleural effusion,

9.

(2003) Prognostic features of residual pleural thickening in parapneumonic pleural effusions ,

10.

(1996) The effect of percutaneous pig-tail catheter drainage in the management of lung abscess and empyema ,

11.

(1996) The evaluation of image-guided catheter drainage in pleural effusion and empyema,

12.

(2003) Efficacy of pigtail catheter drainage in patients with thoracic empyema or complicated parapneumonic effusion,

13.

(2006.12.28.) Helping patients who drink too much. A clinician’s guide,

14.

(2005) Quantifying the risks associated with exceeding recommended drinking limits,

15.

based on European/North American multicenter study. JAMA 1993,

16.

Orringer MB. Modern management of adult thoracic empyema. J Thorac Cardiovasc Surg 1985,

17.

(1999) Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion or empyema,

18.

(2004) Intrapleural streptokinase for empyema and complicated parapneumonic effusions,

19.

(2000) Bronchial reactivity to cigarette smoke: relation to lung function, respiratory symptoms, serum-immunoglobulin E and blood eosinophil and leukocyte counts,

20.

(2006) Smoking and systemic disease,

21.

(1998) Prediction of clinical severity and outcome of ventilator-associated pneumonia,

22.

(2005) SAPS II revisited,

23.

(2006) Comparison of severity of illness scoring systems for patients with nosocomial blood stream infection due to Pseudomonas aerusinosa,

24.

(2000) A comparison of severity of illness scoring systems for elderly patients with severe pneumonia,

25.

(2005) Early use of intrapleural fibrinolytics in the management of postpneumonic empyema,

26.

(1997) Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study,

27.

(1996) Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema,

Tuberculosis & Respiratory Diseases